FR2926021B1 - Utilisation de derives c-glycoside a titre d'actif vasculaire - Google Patents

Utilisation de derives c-glycoside a titre d'actif vasculaire

Info

Publication number
FR2926021B1
FR2926021B1 FR0850029A FR0850029A FR2926021B1 FR 2926021 B1 FR2926021 B1 FR 2926021B1 FR 0850029 A FR0850029 A FR 0850029A FR 0850029 A FR0850029 A FR 0850029A FR 2926021 B1 FR2926021 B1 FR 2926021B1
Authority
FR
France
Prior art keywords
assets
vascular
glycoside derivatives
glycoside
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0850029A
Other languages
English (en)
Other versions
FR2926021A1 (fr
Inventor
Brigitte Lavaud
Claudie Willemin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0850029A priority Critical patent/FR2926021B1/fr
Publication of FR2926021A1 publication Critical patent/FR2926021A1/fr
Application granted granted Critical
Publication of FR2926021B1 publication Critical patent/FR2926021B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0850029A 2008-01-03 2008-01-03 Utilisation de derives c-glycoside a titre d'actif vasculaire Active FR2926021B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0850029A FR2926021B1 (fr) 2008-01-03 2008-01-03 Utilisation de derives c-glycoside a titre d'actif vasculaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0850029A FR2926021B1 (fr) 2008-01-03 2008-01-03 Utilisation de derives c-glycoside a titre d'actif vasculaire

Publications (2)

Publication Number Publication Date
FR2926021A1 FR2926021A1 (fr) 2009-07-10
FR2926021B1 true FR2926021B1 (fr) 2012-12-14

Family

ID=39627393

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0850029A Active FR2926021B1 (fr) 2008-01-03 2008-01-03 Utilisation de derives c-glycoside a titre d'actif vasculaire

Country Status (1)

Country Link
FR (1) FR2926021B1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2994843B1 (fr) * 2012-09-05 2016-08-26 Oreal Utilisation cosmetique de cellules vegetales dedifferenciees
WO2013102882A2 (fr) * 2012-01-05 2013-07-11 L'oreal Utilisation cosmétique de cellules végétales dédifférenciées
FR3007982B1 (fr) * 2013-07-05 2015-08-21 Oreal Stabilisation des cellules dedifferenciees de rose.
FR3130602A1 (fr) * 2021-12-20 2023-06-23 L'oreal Composition contenant l'association d'un C-glycoside et de l'escine pour le soin du contour des yeux
FR3139280A1 (fr) * 2022-09-01 2024-03-08 L'oreal Utilisation d’une association comprenant au moins un C-glycoside, au moins un extrait issu d’une plante de l’espèce Cassia angustifolia et de la caféine, dans une composition, pour prévenir et/ou traiter les signes du vieillissement cutané

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695738A (en) * 1995-06-15 1997-12-09 Glycomed Incorporated Steroidal C-glycosides
FR2768622B1 (fr) * 1997-09-22 1999-11-26 Oreal Extrait de rosacees en tant qu'antagoniste de bradykinine
FR2768621B1 (fr) * 1997-09-22 2000-04-07 Oreal Utilisation d'un extrait d'au moins un vegetal de la famille des rosacees
US6069238A (en) * 1998-09-30 2000-05-30 Eli Lilly And Company Spirocyclic C-glycosides
US6590110B1 (en) * 1998-09-30 2003-07-08 University Of Iowa Research Foundation Method for synthesizing C-glycosides of ulosonic acids
FR2818646B1 (fr) * 2000-12-22 2006-06-23 Oreal Nouveaux derives c-glycoside et utilisation
FR2818547B1 (fr) * 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
EP1679965A4 (fr) * 2003-08-01 2009-05-27 Janssen Pharmaceutica Nv C-glycosides heterocycliques fusionnes substitues
FR2869317B1 (fr) * 2004-04-23 2008-08-29 Oreal Nouveaux derives c-glycosides et utilisations cosmetiques
FR2883171B1 (fr) * 2005-03-15 2007-05-11 Oreal Utilisation d'agents tels que des donneurs ou liberateurs non polymeriques de monoxyde d'azote pour diminuer les poches et/ou les cernes perioculaires
FR2889808B1 (fr) * 2005-08-17 2011-07-22 Oreal Utilisation de l'acide 8-hexadecene-1,16-dicarboxylique comme agent de soin destine a favoriser la cohesion de la couche cornee
FR2903004B1 (fr) * 2006-07-03 2009-07-10 Oreal Utilisation en cosmetique d'un derive c-glycoside en association avec de l'acide ascorbique

Also Published As

Publication number Publication date
FR2926021A1 (fr) 2009-07-10

Similar Documents

Publication Publication Date Title
FR19C1033I2 (fr) Derives phosphores servant d'inhibiteurs de kinase
DK2470518T3 (da) Esterderivater af 2,5-furandicarboxylsyre og deres anvendelse som blødgørere
DK2178840T3 (da) Azabiphenylaminobenzoesyre-derivater som dhodh-hæmmere
BRPI0924411A2 (pt) "dispositivos de oclusão cardíaca"
BRPI1015540A2 (pt) ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750''
CR10400A (es) Derivados de lactamas de ciclohexilpirazol como inhibidores de 11-beta -hidroxiesteroide deshidrogenasa 1
FR2957244B1 (fr) Implant d'arthrodese
BRPI0911122A2 (pt) Artigos absorventes descartáveis microbicidas
BR112013013790A2 (pt) compostos heterocíclos nitrogenosos 6,6-fundidos substituídos e usos dos mesmos
BRPI1007878A2 (pt) "compostos inseticidas"
BRPI0810660A2 (pt) Derivados do ácido lipóico
BRPI1013762A2 (pt) "derivados isoxazol-piridazina"
WO2010128050A3 (fr) Anti-inflammatoires utilisés comme virostatiques
ATE536905T1 (de) Dilatationskatheter
BRPI0908181A2 (pt) Solução de cardioplegia para cirurgia cardíaca
CR10879A (es) Cyclized derivatives as eg-5 inhibitors
FR2917969B1 (fr) Utilisation cosmetique d'un derive d'acide imido-percarboxylique a titre d'agent desquamant
IT1397247B1 (it) Nuovi agenti regolatori dell'attivita' citochinica
DK2155731T3 (da) 1,3-Dihydroimidazol-2-thion-derivater som inhibitorer af dopamin-beta-hydroxylase
FR2902999B1 (fr) Utilisation de derives c-glycoside a titre d'actif prodesquamant
BRPI0819958A2 (pt) "artigo absorvente"
BRPI0917210A2 (pt) exoterma controlada de formulações de cianocrilato
BRPI0811961A2 (pt) Derivados 1,3-diaza-4-oxo-heterocíclicos de 3 a 7 membros capazes de liberar aldeídos ou cetonas ativos
BR112012014449A2 (pt) composições biocidas que compreendem derivados do ácido piroglutâmico
EP2394645A4 (fr) Utilisation médicale de dérivés d'acide 5-benzylaminosalicylique ou de sels correspondants

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17